Showing 621 - 640 results of 1,761 for search '(( 10 ((per decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 2020 us decrease ))*', query time: 0.16s Refine Results
  1. 621
  2. 622
  3. 623
  4. 624
  5. 625

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  6. 626
  7. 627
  8. 628

    Novel fluorinated surfactants for enhanced oil recovery in carbonate reservoirs by Al-Amodi, Adel O.

    Published 2016
    “…However, betaine‐based co‐surfactant reduced the IFT to 10−3 mN/m. An adsorption isotherm showed that the maximum adsorption of surfactant‐A was 1 mg per g of rock. …”
    Get full text
    Get full text
  9. 629

    Absorption of CO2 in aqueous blend of methyldiethanolamine and arginine by Talkhan, Ahmed Gomaa

    Published 2020
    “…The study was carried out at different mixing ratios of MDEA and Arg at a total concentration of 2 moles per litre. The CO2 partial pressure varied from about 10 to 100 kPa, and the temperature varied from 293 K to 323 K. …”
    Get full text
    Get full text
  10. 630
  11. 631
  12. 632
  13. 633

    Synthesizing New Anodes From Qatalum's 1st Cut Spl by Hani Holozadah, Abdullah

    Published 2014
    “…This might result in extending the life time of the carbon anodes and decrease the number of carbon dioxide kilograms that are released per a ton of produced Al metal. …”
    Get full text
    Get full text
  14. 634
  15. 635
  16. 636
  17. 637
  18. 638
  19. 639
  20. 640

    CLINICAL AND ECONOMIC IMPACT OF GENETIC AND NON-GENETIC FACTORS ON INR NORMALIZATION IN PRE-OPERATIVE MANAGEMENT OF WARFARIN PATIENTS by ELJILANY, ISLAM AHMED SAYED AHMED

    Published 2021
    “…To optimize the period of preprocedural warfarin interruption to decrease the incidence of bleeding in case of bridging and the incidence of thromboembolism in case of non-bridging, a study was conducted to determine the influence of CYP2C9, VKORC1, CYP4F2, FII, and FVII genetic polymorphisms and non-genetic factors on INR decline in a cohort of Arabs undergoing a procedure that requires warfarin interruption and developing an algorithm to tailor the duration of warfarin interruption before the procedure. …”
    Get full text